Wynn Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$329K Buy
5,034
+398
+9% +$26.9K 0.15% 95
2026
Q2
$297K Buy
4,636
+447
+11% +$29.4K 0.13% 94
2026
Q1
$298K Buy
4,189
+181
+5% +$14.3K 0.15% 92
2025
Q4
$329K Sell
4,008
-258
-6% -$20.1K 0.16% 91
2025
Q3
$320K Buy
4,266
+189
+5% +$14.1K 0.16% 91
2025
Q2
$302K Sell
4,077
-56
-1% -$3.9K 0.16% 95
2025
Q1
$334K Buy
4,133
+20
+0.5% +$1.72K 0.2% 88
2024
Q4
$322K Buy
4,113
+86
+2% +$7.31K 0.2% 92
2024
Q3
$378K Buy
4,027
+682
+20% +$57.2K 0.25% 78
2024
Q2
$261K Buy
3,345
+220
+7% +$17.9K 0.19% 92
2024
Q1
$284K Buy
3,125
+122
+4% +$10.2K 0.22% 84
2023
Q4
$232K Buy
+3,003
New +$210K 0.19% 93

Other funds holding GEHC

Wynn Capital's GEHC Position: Q3 2026 in Review

Wynn Capital increased its GE HealthCare (GEHC) stake by 8.6% in Q3 2026, buying an estimated $26.9K and bringing the position to 5,034 shares worth $329K. The position accounts for 0.15% of the portfolio, ranked #95.

Wynn Capital first reported a position in GEHC in Q4 2023 and has held it in 12 quarters since. The position peaked at $378K in Q3 2024. 954 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Wynn Capital held 5,034 shares of GE HealthCare worth $329K as of Q3 2026.
  • Wynn Capital bought 398 GE HealthCare shares in Q3 2026, an estimated $26.9K.
  • GE HealthCare made up 0.15% of Wynn Capital's portfolio in Q3 2026, its #95 holding.
  • Wynn Capital first reported a position in GE HealthCare in Q4 2023 and has held it in 12 quarters since.
  • Wynn Capital's GE HealthCare position peaked at $378K in Q3 2024.
  • 954 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Wynn Capital's 13F filing for Q3 2026, filed 13 Oct 2026.